Archive for March 10th, 2009
Armchair Legal Analysis of Schering-J&J Distribution Agreement: The $41 Billion Deal Hinges on This?
By David Feldman at 10 March, 2009, 9:18 am
Sorry guys, this is a little longer than most posts. As mentioned in my previous entry, the Merck-Schering Plough merger is structured as a reverse merger with Schering surviving even though it is the target. This is being done because the parties believe it will not trigger a change in control provision in Schering’s distribution [...]
Read More >>Schering-Merck Plot Biggest Reverse Merger Ever
By David Feldman at 10 March, 2009, 6:37 am
Drug giant Merck is buying other drug giant Schering-Plough for $41.1 billion. This is good news for the beleaguered M&A world, and provides some good news for big pharma. Analysts have generally hailed the move as necessary consolidation given many challenges in the industry even though unfortunately it seems that thousands of jobs may be lost [...]
Read More >>
